Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 129

    1.

    Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue.

    Goldfine AB, Crunkhorn S, Costello M, Gami H, Landaker EJ, Niinobe M, Yoshikawa K, Lo D, Warren A, Jimenez-Chillaron J, Patti ME.

    Diabetes. 2006 Mar;55(3):640-50.PMID: 16505226 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.

    Albrektsen T, Frederiksen KS, Holmes WE, Boel E, Taylor K, Fleckner J.

    Diabetes. 2002 Apr;51(4):1042-51.PMID: 11916924 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy.

    Tan GD, Debard C, Funahashi T, Humphreys SM, Matsuzawa Y, Frayn KN, Karpe F, Vidal H.

    Diabetologia. 2005 Aug;48(8):1585-9. Epub 2005 Jul 1.PMID: 15991021 [PubMed - indexed for MEDLINE]Related articles

    4.

    Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.

    Hoo RL, Chow WS, Yau MH, Xu A, Tso AW, Tse HF, Fong CH, Tam S, Chan L, Lam KS.

    Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2777-82. Epub 2007 Oct 11.PMID: 17932317 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin.

    Tseng YH, Butte AJ, Kokkotou E, Yechoor VK, Taniguchi CM, Kriauciunas KM, Cypess AM, Niinobe M, Yoshikawa K, Patti ME, Kahn CR.

    Nat Cell Biol. 2005 Jun;7(6):601-11. Epub 2005 May 15.PMID: 15895078 [PubMed - indexed for MEDLINE]Related articles

    6.

    The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.

    Li YY, Wu HS, Tang L, Feng CR, Yu JH, Li Y, Yang YS, Yang B, He QJ.

    Pharmacol Res. 2007 Oct;56(4):335-43. Epub 2007 Aug 9.PMID: 17889553 [PubMed - indexed for MEDLINE]Related articles

    7.

    Hepatocyte growth factor secreted by cultured adipocytes promotes tube formation of vascular endothelial cells in vitro.

    Saiki A, Watanabe F, Murano T, Miyashita Y, Shirai K.

    Int J Obes (Lond). 2006 Nov;30(11):1676-84. Epub 2006 Mar 21.PMID: 16552403 [PubMed - indexed for MEDLINE]Related articles

    8.

    Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.

    Kim HJ, Jung TW, Kang ES, Kim DJ, Ahn CW, Lee KW, Lee HC, Cha BS.

    Metabolism. 2007 May;56(5):676-85.PMID: 17445544 [PubMed - indexed for MEDLINE]Related articles

    9.

    Modulation of carbohydrate response element-binding protein gene expression in 3T3-L1 adipocytes and rat adipose tissue.

    He Z, Jiang T, Wang Z, Levi M, Li J.

    Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E424-30. Epub 2004 Apr 20.PMID: 15100094 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Ectopic expression of necdin induces differentiation of mouse neuroblastoma cells.

    Kobayashi M, Taniura H, Yoshikawa K.

    J Biol Chem. 2002 Nov 1;277(44):42128-35. Epub 2002 Aug 26.PMID: 12198120 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.

    Kershaw EE, Schupp M, Guan HP, Gardner NP, Lazar MA, Flier JS.

    Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1736-45. Epub 2007 Sep 11.PMID: 17848638 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans.

    Phillips SA, Kung J, Ciaraldi TP, Choe C, Christiansen L, Mudaliar S, Henry RR.

    Am J Physiol Endocrinol Metab. 2009 Sep;297(3):E767-73. Epub 2009 Jul 21.PMID: 19622782 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation.

    Hutley LJ, Newell FM, Joyner JM, Suchting SJ, Herington AC, Cameron DP, Prins JB.

    Eur J Clin Invest. 2003 Jul;33(7):574-81.PMID: 12814394 [PubMed - indexed for MEDLINE]Related articles

    14.

    Increased adipose tissue expression of Grb14 in several models of insulin resistance.

    Cariou B, Capitaine N, Le Marcis V, Vega N, Béréziat V, Kergoat M, Laville M, Girard J, Vidal H, Burnol AF.

    FASEB J. 2004 Jun;18(9):965-7. Epub 2004 Apr 1.PMID: 15059968 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.

    Chang CH, McNamara LA, Wu MS, Muise ES, Tan Y, Wood HB, Meinke PT, Thompson JR, Doebber TW, Berger JP, McCann ME.

    Eur J Pharmacol. 2008 Apr 14;584(1):192-201. Epub 2008 Feb 14.PMID: 18346728 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effects of chronic rosiglitazone therapy on gene expression in human adipose tissue in vivo in patients with type 2 diabetes.

    Kolak M, Yki-Järvinen H, Kannisto K, Tiikkainen M, Hamsten A, Eriksson P, Fisher RM.

    J Clin Endocrinol Metab. 2007 Feb;92(2):720-4. Epub 2006 Dec 5.PMID: 17148569 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone.

    Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, Straubhaar J, Czech MP, Corvera S.

    J Clin Invest. 2004 Nov;114(9):1281-9.PMID: 15520860 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Assessment of fat-specific protein 27 in the adipocyte lineage suggests a dual role for FSP27 in adipocyte metabolism and cell death.

    Kim JY, Liu K, Zhou S, Tillison K, Wu Y, Smas CM.

    Am J Physiol Endocrinol Metab. 2008 Apr;294(4):E654-67. Epub 2008 Jan 15.PMID: 18198355 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.

    Kalsekar I, Iyer S, Mody R, Rajagopalan R, Kavookjian J.

    J Manag Care Pharm. 2006 Mar;12(2):121-9.PMID: 16515370 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data